A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05).

Autor: Conde-Moreno AJ; Department Radiation Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Electronic address: conde_ant@gva.es., López-Campos F; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Hervás A; Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Morillo V; Department of Radiation Oncology, Hospital Provincial de Castellón, Spain., Méndez A; Department of Radiation Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Puertas MDM; Department Radiation Oncology, Hospital Miguel Servet, Zaragoza, Spain., Valero-Albarrán J; Department of Radiation Oncology, Hospital HM, Madrid, Spain., Gómez Iturriaga A; Department of Radiation Oncology Hospital Universitario Cruces, Biobizkaia Health Research Institute Basque Country University UPV/EHU, Barakaldo, Spain., Rico M; Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain., Vázquez ML; Department of Radiation Oncology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain., Samper Ots PM; Department of Radiation Oncology, Hospital Universitario Rey Juan Carlos, Móstoles, Spain., Perez-Romasanta LA; Department of Radiation Oncology, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Pastor J; Department of Radiation Oncology, Hospital ASCIRES, Valencia, Spain., Ibáñez C; Department of Radiation Oncology, Hospital Universitario Gómez Ulla, Madrid, Spain., Ferrer F; Department of Radiation Oncology, Institut Catalá de Oncología, Hospital Universitario de Belvitge, Barcelona, Spain., Zapatero A; Department of Radiation Oncology, Hospital Universitario de la Princesa, Madrid, Spain., García-Blanco AS; Department of Radiation Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Rodríguez A; Department of Radiation Oncology, Hospital Ruber Internacional, Madrid, Spain., Ferrer C; Department of Radiation Oncology, Hospital Provincial de Castellón, Spain.

Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2024 Sep-Oct; Vol. 14 (5), pp. e344-e352. Date of Electronic Publication: 2024 Jun 29.

Impact of covid-19 on patients in radiotherapy oncology departaments in Spain.

Autor: Samper Ots PM; Hospital Rey Juan Carlos Móstoles Madrid, Spain. Electronic address: pisamot@gmail.com., Zapatero Ortuño J; Hospital Rey Juan Carlos Móstoles Madrid, Spain. Electronic address: jose.ortuno@hospitalreyjuancarlos.es., Pedraza Fernández S; Hospital 12 de Octubre Madrid, Spain., Mayrata Canellas E; Hospital Universitario Cruces Bilbao, Spain. Electronic address: ESTHER.MAYRATACANELLAS@osakidetza.eus., González San Segundo C; Hospital General Universitario Gregorio Marañón Madrid, Spain., Campo Vargas M; Hospital Universitario de Álava (Txagorritxu), Spain. Electronic address: maider.campovargas@osakidetza.eus., Caballero B; Hospital de Fuenlabrada Madrid, Spain. Electronic address: begona.caballero@salud.madrid.org., Ramos Albiac M; Hospital de Vall d'Hebron Barcelona, Spain. Electronic address: monramos@vhebron.net., Vázquez Masedo G; Hospital Clinico de Madrid, Spain., Álvarez B; Hospital Madrid Sanchinarro Puerta del Sur Madrid, Spain. Electronic address: balvarez@hmhospitales.com., Rodríguez Villalba S; Hospital Clínica Benidorm Alicante, Spain. Electronic address: srodriguez@clinicabenidorm.com., Muñoz Miguelañez T; Hospital Ramón y Cajal Madrid, Spain., Diezhandino Garcia P; Hospital Clinico Universitario Valladolid, Spain. Electronic address: pdiezhandino@saludcastillayleon.es., Sancho G; Hospital Sant Pau Barcelona, Spain. Electronic address: Gsancho@santpau.cat., Guzmán Gómez L; Fundación Jiménez Diaz Madrid, Spain. Electronic address: auraguzmang@quironsalud.es., Tripero J; Genesiscare Guadalajara, Spain., Rico Oses MR; Complejo Hospitalario de Navarra, Spain. Electronic address: Mikel.rico.oses@navarra.es., Ibañez Villoslada C; Hospital Central de la Defensa Gomez Ulla Madrid, Spain., Soler Rodríguez AMS; Hospital Universitario de La Ribera Valencia, Spain., Chust ML; Fundación IVO Valencia, Comunidad Valenciana, Spain. Electronic address: mchust@fivo.org., Fondevilla Soler A; GenesisCare Murcia, Spain. Electronic address: adriana.fondevilla@genesiscare.es., Lozano Martin EM; Hospital General Universitario Ciudad Real, Spain., Morillo Macias V; Hospital Provincial Castellón, Spain., Fuentes Sánchez C; Hospital Universitario de la Candelaria Canarias, Spain., Torrado Moya L; Hospital Universitario Lucus Augusti HULA Galicia, Spain., Fernández López J; IVO Cuenca, Spain. Electronic address: jfernandez@fivo.org., Solé JM; Hospital de Terrasa Cataluña, Spain. Electronic address: Jmsole@cst.cat., Guijarro Verdú M; Genesiscare San Francisco de Asís Madrid, Spain. Electronic address: marcos.guijarro@genesiscare.es., Mira Flores M; Hospital Universitario Arnau de Vilanova Lérida, Spain., Wals A; Hospital Virgen Macarena Sevilla, Spain., Expósito Hernández J; Hospital Virgen de las Nieves Granada, Spain.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Aug; Vol. 161, pp. 148-151. Date of Electronic Publication: 2021 Jun 10.

SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study.

Autor: Samper Ots PM; Department of Radiation Oncology, Rey Juan Carlos Hospital, Madrid, Spain., Muñoz García JL; Department of Radiation Oncology, Infanta Cristina Hospital, Madrid, Spain., Ríos Kavadoy Y; Department of Radiation Oncology, Infanta Cristina Hospital, Madrid, Spain., Couselo Paniagua ML; Department of Radiation Oncology, Gómez Ulla Hospital, Spain., Villafranca Iturre E; Department of Radiation Oncology, Navarra Hospital, Spain., Rodríguez Liñán M; Department of Radiation Oncology, Reina Sofía Hospital, Spain., Pérez Casas AM; Department of Radiation Oncology, Jiménez Díaz Hospital, Spain., Soria RM; Department of Radiation Oncology, Provincial Hospital of Castellón, Spain., Martínez BL; Department of Radiation Oncology, Fuenlabrada Hospital, Spain., Torrecilla JL; Department of Radiation Oncology, General University Hospital of Valencia, Spain., Giner MC; Department of Radiation Oncology, Fundación IVO Valencia, Spain., Laborda AZ; Department of Radiation Oncology, La Princesa Hospital, Spain., García-Salazar MM; Department of Radiation Oncology, Juan Ramón Jiménez Hospital, Spain.

Publikováno v: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2015 Sep-Oct; Vol. 20 (5), pp. 370-6. Date of Electronic Publication: 2015 Sep 29.

Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed.

Autor: Rodríguez Pérez A; Radiation Oncology Department, Hospital Central de la Defensa Gómez-Ulla, Madrid, Spain., Samper Ots PM, López Carrizosa MC, Pérez-Regadera Gómez JF, Zapatero Ortuño J, Sáez Garrido Jde D, Martín de Miguel MJ

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2012 May; Vol. 14 (5), pp. 362-8.

PITASOR epidemiological study: prevalence, incidence and treatment of anaemia in radiation therapy oncology departments in Spain.

Autor: Samper Ots PM; Servicio de Oncología Radioterápica, Hospital Central de Defensa Gómez Ulla, Madrid, Spain. psamots@oc.mde.es, Muñoz J, Biete A, Ortiz MJ, Acuña M, Cabrera J, López Carrizosa C, Bayo E, Herruzo I, Pérez MM, Domínguez MA, Morillo Macías V, Mira M, Pérez Casas AM, Sevillano MM, García Ríos I, Andreu F, Sotoca A, Álvarez A, López E, Pérez Escutia MÁ, Loayza Villaroel A

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2011 May; Vol. 13 (5), pp. 322-7.